You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ofatumumab

Showing 26 - 50 of 81
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis Trial in Worldwide (Ofatumumab, First line DMT)

Recruiting
  • Multiple Sclerosis
  • Ofatumumab
  • First line DMT
  • Bayonne, Bayonne Cedex, France
  • +42 more
Jul 25, 2022

Follicular Lymphoma, Grade 1, Follicular Lymphoma, Grade 2, Follicular Lymphoma Grade 3A Trial in Italy (OFATUMUMAB)

Completed
  • Follicular Lymphoma, Grade 1
  • +2 more
  • OFATUMUMAB
  • Alessandria, AL, Italy
  • +26 more
Jun 16, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Duvelisib, Ofatumumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
  • +91 more
Dec 14, 2021

Nephrotic Syndrome Trial in Genoa (Ofatumumab, Placebo)

Terminated
  • Nephrotic Syndrome
  • Ofatumumab
  • Placebo
  • Genoa, Italy/GE, Italy
    IRCCS Istituto Giannina Gaslini
Jul 28, 2020

Chronic Lymphocytic Leukemia Trial in Cologne (Bendamustine, Ofatumumab, Ibrutinib)

Completed
  • Chronic Lymphocytic Leukemia
  • Cologne, Germany
    German CLL Study Group
Jun 9, 2020

Nephrotic Syndrome Trial in Genoa (Ofatumumab, Rituximab)

Completed
  • Nephrotic Syndrome
  • Genoa, Italy/GE, Italy
    IRCCS Istituto Giannina Gaslini
Jul 28, 2020

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (IPI-145 (duvelisib), Ofatumumab)

Completed
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • IPI-145 (duvelisib)
  • Ofatumumab
  • La Jolla, California
  • +68 more
Mar 15, 2021

Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, Burkitt Leukemia Trial in Houston (drug,

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 6, 2021

B-cell Lymphoid Leukemia, Young Patients Trial in Italy (Cyclophosphamide, Fludarabine, Ofatumumab)

Completed
  • B-cell Lymphoid Leukemia
  • Young Patients
  • Alessandria, Italy
  • +21 more
Oct 12, 2020

Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2022

Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Idelalisib,

Completed
Has Results
  • Indolent Non-Hodgkin's Lymphoma
  • +2 more
  • Huntsville, Alabama
  • +10 more
Feb 22, 2021

Chronic Lymphocytic Leukemia, Fatigue, Fever Trial in Houston (Lenalidomide, Ofatumumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 16, 2019

Non-Hodgkin's Lymphoma Trial in Grand Island, Omaha (Lenalidomide, ofatumumab)

Completed
Has Results
  • Non-Hodgkin's Lymphoma
  • Grand Island, Nebraska
  • +1 more
Feb 20, 2019

Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (ofatumumab, ibrutinib)

Completed
Has Results
  • Relapsed or Refractory Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • La Jolla, California
  • +75 more
Dec 3, 2019

Lymphoma, Follicular Trial in Worldwide (Ofatumumab, Bendamustine infusion, Ofatumumab and Bendamustine infusions (Arm A))

Terminated
Has Results
  • Lymphoma, Follicular
  • Ofatumumab
  • +3 more
  • Tucson, Arizona
  • +139 more
Mar 25, 2020

Acute Lymphoblastic Leukemia in Remission, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia

Terminated
Has Results
  • Acute Lymphoblastic Leukemia in Remission
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 18, 2021

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Ofatumumab)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • Duarte, California
  • +79 more
Aug 5, 2019

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial in Houston (biological, drug, other)

Recruiting
  • B Acute Lymphoblastic Leukemia
  • B Lymphoblastic Lymphoma
  • Blinatumomab
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 21, 2021

Lymphoma, Non-Hodgkin Trial in United States (Ofatumumab, Bendamustine)

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • Chandler, Arizona
  • +21 more
Aug 6, 2018

Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia Trial in United States

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • +9 more
  • Scottsdale, Arizona
  • +3 more
Aug 20, 2018

Chronic Lymphocytic Leukemia, B-Cell Non-Hodgkin's Lymphoma Trial in Philadelphia (Bendamustine, Pentostatin, Ofatumumab)

Terminated
  • Chronic Lymphocytic Leukemia
  • B-Cell Non-Hodgkin's Lymphoma
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
May 23, 2018

Leukemia, Precursor-B Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Houston (Cytarabine, Daunorubicin,

Terminated
Has Results
  • Leukemia
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 9, 2018

Patients With CLL Relapsing After an Initial Response (CR, PR = 6 Months) Following no More Than Two Prior Treatment Lines; or,

Completed
Has Results
  • Patients With CLL Relapsing After an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or
  • Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment Lines
  • Ascoli, Italy
  • +31 more
Jan 24, 2019

Richter's Syndrome Trial in United Kingdom (Ofatumumab)

Completed
  • Richter's Syndrome
  • Ofatumumab
  • Birmingham, United Kingdom
  • +8 more
Apr 23, 2018

Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Columbus (drug, other,

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 15, 2018